SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-10-014136
Filing Date
2010-03-17
Accepted
2010-03-17 16:49:09
Documents
2
Period of Report
2009-07-23
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 v177797_8ka.htm 8-K/A 27305
2 v177797_ex16-1.htm EX-16.1 5682
  Complete submission text file 0001144204-10-014136.txt   34774
Mailing Address 710 POST OAK SUITE 410 HOUSTON TX 77024
Business Address 710 POST OAK SUITE 410 HOUSTON TX 77024 713-780-0806
Oncolin Therapeutics, Inc. (Filer) CIK: 0001229089 (see all company filings)

IRS No.: 880507007 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K/A | Act: 34 | File No.: 000-50541 | Film No.: 10689234
SIC: 2834 Pharmaceutical Preparations